Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Research and Practice in Thrombosis and Haemostasis|February 4, 2021
Forming megakaryocytes from murine-induced pluripotent stem cells by the inducible overexpression of supporting factorsKatharina Cullmann, Magdalena Jahn, Markus Spindler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2012
Lentiviral vector induced insertional haploinsufficiency of Ebf1 causes murine leukemiaDirk Heckl, Adrian Schwarzer, Reinhard Haemmerle, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 13, 2009
Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectorsUte Modlich, Susana Navarro, Daniela Zychlinski, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2012
Alpharetroviral self-inactivating vectors: long-term transgene expression in murine hematopoietic cells and low genotoxicityJulia D Suerth, Tobias Maetzig, Martijn H Brugman, et al.
Genes, Chromosomes & Cancer|January 24, 2013
Histone methyltransferase Suv39h1 deficiency prevents Myc-induced chromosomal instability in murine myeloid leukemiasBeate Vajen, Ute Modlich, Andrea Schienke, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 7, 2015
Lentiviral gene therapy using cellular promoters cures type 1 Gaucher disease in miceMaria Dahl, Alexander Doyle, Karin Olsson, et al.
EMBO Molecular Medicine|September 19, 2018
Anett Pfeiffer, Frederic B Thalheimer, Sylvia Hartmann, et al.
Human Gene Therapy. Clinical Development|April 18, 2018
Non-Clinical Efficacy and Safety Studies on G1XCGD, a Lentiviral Vector for Ex Vivo Gene Therapy of X-Linked Chronic Granulomatous DiseaseChristian Brendel, Michael Rothe, Giorgia Santilli, et al.
Experimental Hematology|December 10, 2003
Predictable and efficient retroviral gene transfer into murine bone marrow repopulating cells using a defined vector doseZhixiong Li, Maike Schwieger, Claudia Lange, et al.
Molecular Pharmaceutics|August 20, 2011
Development of novel efficient SIN vectors with improved safety features for Wiskott-Aldrich syndrome stem cell based gene therapyInés Avedillo Díez, Daniela Zychlinski, Emanuele G Coci, et al.
Pageof 7